Zeo ScientifiX (ZEOX) Revenue Growth (3y) (2016 - 2026)
Zeo ScientifiX (ZEOX) Revenue Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 10.17% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 10.76% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 77.85% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -25.02% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 42.02% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 59.40% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -37.68% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 76.62% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 7.80% |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn | 45.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 45.09% |
| Jan 31, 2026 | 10.56% |
| Oct 31, 2025 | 4.64% |
| Jul 31, 2025 | -8.65% |
| Apr 30, 2025 | -12.84% |
| Jan 31, 2025 | -11.99% |
| Oct 31, 2024 | -9.28% |
| Jul 31, 2024 | -7.26% |
| Apr 30, 2024 | -1.82% |
| Jan 31, 2024 | -5.52% |
| Oct 31, 2023 | 13.09% |
| Jul 31, 2023 | 16.75% |
| Apr 30, 2023 | 11.58% |
| Jan 31, 2023 | 15.36% |
| Oct 31, 2022 | 35.08% |
| Jul 31, 2022 | 43.59% |
| Apr 30, 2022 | 68.61% |
| Jan 31, 2022 | 108.69% |
| Oct 31, 2021 | 88.66% |
| Jul 31, 2021 | 87.90% |